Skip to main content

Table 4 Relapses

From: Vision loss in patients with giant cell arteritis treated with tocilizumab

Tocilizumab 1st relapse  
  N (%) joint p value*
   < 0.001
During treatment 18/186 (9.7%)  
Before treatment 25/186 (13.4%)  
After treatment 24/67 (35.8%)  
  1. *p value from a Pearson Chi2 test